Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
BACKGROUND
Tissue factor (TF) is an initiator of coagulation. The serine protease factor Xa (FXa) is the convergence point of the extrinsic and intrinsic components of the coagulation cascade. In addition to its hemostatic function, FXa elicits inflammatory responses in endothelial cells that may be important in surgical procedures in which inflammation is triggered. This study tested the hypothesis that FXa can up-regulate TF on vascular endothelial cells by a mitogen-activated protein kinase (MAPK)- and NF-κB-dependent pathway.


RESULTS
Incubation of cultured human umbilical vein endothelial cells (HUVECs) with FXa increased TF protein expression and activity in a dose-dependent manner. Pre-incubation of HUVECs with the serine protease inhibitor antithrombin, which targets not only thrombin but also FXa and FIXa, inhibited FXa-induced TF expression, but the selective thrombin inhibitor hirudin did not inhibit FXa-induced TF expression, ruling out a thrombin-mediated pathway. After 10 min incubation with HUVECs, FXa rapidly induced P44/42 MAPK activation (immunoblotting of phosphorylated P44/42 MAPK) with a peak at 30 min. The MEK 1/2 inhibitor PD98059 partially reduced FXa-induced TF expression and activity (3.82 ± 0.11 vs 6.54 ± 0.08 fmol/min/cm(2), P < 0.05). NF-κB was activated by FXa, confirmed by cytoplasmic IkBα degradation and increased NF-κB P65 nuclear translocation. Interruption of the NF-κB pathway by the IkBα phosphorylation inhibitor Bay 11-7802 abrogated FXa-induced TF protein expression and activity (1.93 ± 0.02 versus 6.54 ± 0.08 fmol/min/cm(2), P < 0.05). However, inhibition of PI3 kinase by LY 294002 did not attenuate FXa-induced TF protein expression and activity.


CONCLUSIONS
(1) FXa up-regulates TF protein expression and activity in HUVECs, (2) FXa-induced up-regulation of TF is independent of the thrombin-PAR1 pathway, and (3) the MAPK and NF-κB pathways, but not PI3 kinase pathway, are involved in FXa-induced TF expression on human umbilical endothelial cells. FXa may be a feed-forward alternative mechanism of activating TF expression and activity, thereby increasing a procoagulant state or inflammation. This mechanism may be important in the pro-inflammatory state initiated by cardiac surgical procedures.
Jiang
Rong
R
Cardiothoracic Research Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University Hospital Midtown, Atlanta, Georgia, USA.
Wang
Ning-Ping
NP
Tanaka
Kenichi A
KA
Levy
Jerrold H
JH
Guyton
Robert A
RA
Zhao
Zhi-Qing
ZQ
Vinten-Johansen
Jakob
J
D000991:Antithrombins / Q000494:pharmacology; D002478:Cells, Cultured; D002867:Chromones / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D015951:Factor Xa / Q000494:pharmacology*; D005419:Flavonoids / Q000494:pharmacology; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D048369:MAP Kinase Kinase 1 / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D009025:Morpholines / Q000494:pharmacology; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D009570:Nitriles / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000187:drug effects / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D013450:Sulfones / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism*; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
D000991:Antithrombins; D002867:Chromones; D015951:Factor Xa; D005419:Flavonoids; D006629:Hirudins; D048369:MAP Kinase Kinase 1; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D009025:Morpholines; D016328:NF-kappa B; D009570:Nitriles; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D013450:Sulfones; D013917:Thrombin; D013925:Thromboplastin; C434003:3-(4-methylphenylsulfonyl)-2-propenenitrile; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Int J Cardiol. 2001 Apr;78(2):115-9
11334654
Shock. 2002 Feb;17(2):159-62
11837793
Blood. 2001 May 15;97(10):3109-16
11342437
J Thorac Cardiovasc Surg. 2002 Nov;124(5):942-9
12407377
Trends Cardiovasc Med. 2005 Feb;15(2):69-75
15885573
J Clin Invest. 1973 Nov;52(11):2745-56
4355998
Ann Thorac Surg. 2003 Jan;75(1):210-5; discussion 215-6
12537218
Cell. 2002 Apr;109 Suppl:S81-96
11983155
J Biol Chem. 2004 Apr 2;279(14):13729-37
14736878
Cardiovasc Res. 1996 Oct;32(4):733-42
8915191
Blood. 1998 Jun 1;91(11):4164-72
9596663
Biochem Pharmacol. 1999 Mar 15;57(6):603-10
10037444
Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1618-26
15937101
Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):461-6
15550696
J Immunol. 1998 Oct 15;161(8):4318-24
9780208
Biochim Biophys Acta. 2006 Aug;1763(8):860-9
16765466
J Biol Chem. 2004 Aug 20;279(34):36142-7
15201277
Arterioscler Thromb Vasc Biol. 1995 May;15(5):612-21
7749875
Circ Res. 2004 Aug 6;95(3):230-2
15242972
J Biol Chem. 2001 Sep 7;276(36):33428-34
11445586
J Thromb Haemost. 2003 Sep;1(9):1935-44
12941034
Blood. 2001 Feb 1;97(3):692-9
11157486
Cardiovasc Res. 2002 Feb 1;53(2):313-25
11827681
Circ Res. 1996 Aug;79(2):286-94
8756006
Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):281-9
9974408
J Biol Chem. 1996 Nov 8;271(45):28407-13
8910465
J Clin Invest. 1995 Jun;95(6):2510-9
7539452
FASEB J. 1995 Jul;9(10):883-9
7615158
Surgery. 2001 Nov;130(5):809-18
11685190
J Infect Dis. 2002 Nov 1;186(9):1270-6
12402196
Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):365-74
9081693
Ann Thorac Surg. 1996 Nov;62(5):1549-57
8893613
Thromb Res. 2001 Aug 15;103(4):281-97
11562339
Haematologica. 2002 Jul;87(7):740-5; discussion 745
12091125
J Biol Chem. 1994 Aug 19;269(33):20823-5
8063696
Circulation. 2002 Apr 16;105(15):1756-9
11956113
Biochemistry. 1997 Mar 18;36(11):3319-30
9116010
Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E107-12
11073863